Nuno Vale is a Principal Investigator at the Center
for Health Technology and Services Research (CINTESIS), where he is Group
Leader of PerMed, and an Invited Associate Professor at the Faculty of Medicine of
the University of Porto (FMUP), as well as holding the Invited Chair of
Innovation in Oncology and Director of the SPARK Program in Digital Health and
Biomedical Innovation positions at FMUP. He has a degree and a Ph.D. from the Faculty of
Sciences of the University of Porto (FCUP) and specializes in pharmaceutical
and peptide chemistry and molecular pharmacology for personalized medicine. In
research, he coordinates projects focused on various pathologies, including
oncology, the central nervous system, and infectiology, in collaboration with
several institutions and companies in the pharmaceutical and clinical fields.
He has published more than 260 scientific articles. His main field of interest
is personalized medicine through his studies in PBPK pharmacological
simulation, drug reuse, synergistic drug combinations, neurotransmitters,
clinical trials, peptides applied to pharmacological medicine, and new
biomarkers for translational medicine.